VC firms

Director, Corporate Strategy

Flagship Pioneering · Cambridge, MA USA · On-site

← All jobs
About Flagship Pioneering

Pioneering Partnerships Latest News.

About the role

Vesalius Therapeutics is seeking a highly analytical, execution-oriented Director of Corporate Development to help lead enterprise strategy, external partnering, and investor engagement. This individual will work closely with senior leadership and cross-functional teams to translate scientific, clinical, competitive, and financial information into clear strategic choices, compelling external narratives, and coordinated action.

What they're looking for

  • 8+ years of relevant experience in biotechnology or pharmaceutical business development, investor relations, corporate strategy, management consulting, investment banking, or a comparable role
  • Demonstrated experience across at least two of the following areas: business development, investor relations, and corporate or portfolio strategy, with the ability to contribute effectively across all three
  • Strong understanding of biotechnology R&D, clinical development, portfolio strategy, partnering, and the drivers of enterprise value
  • Experience evaluating partnerships or licensing opportunities, including diligence, valuation, financial modeling, and transaction support
  • Exceptional written and verbal communication skills, with the ability to translate complex scientific and clinical information into clear investor, partner, executive, and Board materials
  • Demonstrated ability to lead cross-functional work, manage multiple high-priority workstreams, and build external relationships without relying on formal authority
More about this role

Shape strategy, partnerships, and investor engagement at a pivotal point in Vesalius's growth and clinical evolution.

Vesalius Therapeutics has built a unique AI-enabled platform to identify disease-causing biology pairing the world’s largest iPSC collection with state-of-the-art cellular models and rich phenotypic screens. The platform uses genetics as the arbiter of causality to translate human biology into therapeutic hypotheses, and generate rigorous, decision-enabling evidence for drug development programs. Vesalius has formed a strategic collaboration with GSK in Parkinson’s disease and is pursuing multiple other avenues in neurodegeneration and indications outside the CNS. We are also advancing a novel therapeutic program in Alzheimer’s disease.

Vesalius Therapeutics is seeking a highly analytical, execution-oriented Director of Corporate Development to help lead enterprise strategy, external partnering, and investor engagement. This individual will work closely with senior leadership and cross-functional teams to translate scientific, clinical, competitive, and financial information into clear strategic choices, compelling external narratives, and coordinated action.

The...

Read the full posting on Flagship Pioneering's site ↗

G&A

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.